Neuronetics spotlights real-world NeuroStar TMS outcomes data at Clinical TMS Society meeting

Microsoft Corporation
NEURONETICS, INC.

Microsoft Corporation

MSFT

0.00

NEURONETICS, INC.

STIM

0.00
  • Neuronetics flagged new real-world research from its TrakStar database, with findings scheduled for presentation at the Clinical TMS Society meeting on June 5-6.
  • The analyses indicate TMS delivered antidepressant benefits across varied patient groups, including adolescents and adults, with outcomes assessed by age and sex.
  • A separate presentation will discuss maintenance TMS aimed at sustaining patient improvement, supporting broader use beyond initial acute treatment courses.
  • The update reinforces a strategy centered on real-world evidence to support NeuroStar’s positioning in depression care and adjacent indications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuronetics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020832PRIMZONEFULLFEED9730059) on June 02, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.